News
3h
HealthDay on MSNFDA approves ketamine product for surgical pain management
The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management.
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that causes the gradual loss of motor neurons in the brain and spinal cord, leading to muscle weakness, paralysis, and ...
SineuGene gets China NMPA & US FDA nods to initiate phase I/IIa trial of gene therapy, SNUG01 to treat amyotrophic lateral sclerosis: Beijing Monday, August 18, 2025, 18:00 Hrs [I ...
Stanford University scientists have developed a brain implant designed to "hear" and vocalize words a person with severe ...
Yet another biotech is facing a delay from the Food and Drug Administration as the agency reels from intense staffing cuts. | Yet another biotech is facing a delay from the Food and Drug ...
Mark Kirton, who experienced his most productive seasons of his NHL career with the Detroit Red Wings in the early 1980s, ...
Former Peterborough Pete, Toronto Maple Leaf Mark Kirton dies at 67 after seven-year battle with ALS
Mark Kirton was mortal, but his attitude was “super human”, says his former junior hockey coach. The Peterborough Petes and ...
Former Detroit Red Wings forward Mark Kirton, who enjoyed the most productive seasons of his NHL career with the franchise, has tragically lost his battle against ALS and passed away Sunday at just 67 ...
Researchers genetically reprogrammed mouse nerve cells to reverse cell aging, delaying the onset of ALS symptoms in the animals.
In the beginning, not even Hynek Wichterle's postdoc thought his idea to slow the progression of amyotrophic lateral ...
A patient with amyotrophic lateral sclerosis (ALS) has become the first person in the world to control an iPad entirely by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results